查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1912806

絲素蛋白市場按產品類型、來源、應用和最終用戶分類－全球預測（2026-2032 年）

Silk Fibroin Market by Product Form, Source, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，絲素蛋白市場價值將達到 19.5 億美元，到 2026 年將成長到 20.9 億美元，到 2032 年將達到 36.2 億美元，年複合成長率為 9.23%。

關鍵市場統計數據
基準年 2025 19.5億美元
預計年份：2026年 20.9億美元
預測年份 2032 36.2億美元
複合年成長率 (%) 9.23%

一本權威指南，說明了絲素蛋白的多學科重要性、材料特性以及在工業應用中的實用化途徑。

絲素蛋白已超越其在紡織業的傳統應用，成為多個工業領域廣泛研究的功能性生物材料。其獨特的胺基酸組成和層級結構賦予其高拉伸強度、可調控的生物分解性和生物相容性，研究人員和開發人員正利用這些特性來彌合實驗室研究與商業應用之間的鴻溝。在過去十年間，學術研究團隊、Start-Ups公司和工業研發團隊不斷推進加工技術的發展，拓展了絲素蛋白的形態，使其從纖維和薄膜擴展到水凝膠、粉末和支架，從而為再生醫學和高性能紡織品領域開闢了新的設計空間。

關鍵的技術、監管和永續性因素正在匯聚，加速絲素蛋白在多個產業和應用領域的商業化進程。

過去五年，多項變革匯聚一堂，重塑了絲素蛋白的研究、生產和商業化方式。重組蛋白表現和生物製程的進步，使原料來源不再局限於蠶業，從而建立了穩定的供應鏈並實現了客製化的分子設計。同時，積層製造和精密靜電紡絲技術的成熟，使得大規模生產可重複的絲素蛋白構建體成為可能，並滿足臨床和工業應用的需求。這些技術基礎打破了概念驗證研究與目標產品開發之間的傳統壁壘，加速了迭代改進，並催生了新的應用領域。

評估2025年關稅政策對絲素蛋白相關人員的策略供應鏈、採購和夥伴關係的影響

美國2025年實施的關稅政策為全球絲素蛋白供應鏈和定價帶來了新的複雜性。這些關稅提高了某些生物聚合物原料和中間產品的進口成本，迫使製造商重新評估其籌資策略、本地生產方案和垂直整合機會。這些不利因素促使一些公司加快國內產能的投資，或在免稅地區尋找替代供應商，以保持競爭力。

細分市場分析重點在於應用需求、產品形式、終端使用者行為和生物來源等影響絲素蛋白開發策略的因素。

要了解絲素蛋白的市場機遇，需要根據應用、產品形式、最終用戶和生物來源進行細緻的細分。就應用而言，這種材料的多功能性涵蓋了醫療領域，例如藥物傳輸、組織工程和傷口敷料；化妝品領域，例如頭髮和護膚；醫療設備，包括植入和縫合線；以及紡織品應用領域，涵蓋功能性布料和智慧紡織品。每種應用途徑都有其獨特的性能標準和法規要求，從而決定了研發重點和必要的檢驗步驟。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和策略考量對絲素蛋白商業化和供應鏈的影響

區域趨勢將在塑造絲素蛋白的研究重點、供應鏈設計和商業化路徑方面發揮關鍵作用。在美洲，轉化生物醫學研究中心和特種纖維製造商的需求強勁，他們優先考慮與成熟的臨床和消費供應鏈進行整合。該地區的投資者和企業往往重視本土生產能力以及與國家監管機構的協調一致，從而促進將學術創新與合約研發生產機構（CDMO）聯繫起來的夥伴關係。

技術能力、生產規模和策略夥伴關係所塑造的競爭格局決定了絲素蛋白價值鏈中的優勢。

絲素蛋白生態系統中的主要企業包括專業的生物技術公司、材料創新者和成熟的製造商，它們正將自身的核心競爭力應用於新的產品領域。技術領導企業已投資於重組表達平台、專有的下游純化方法以及可擴展的紡絲和流延技術，從而確保材料性能的穩定性。這些公司往往優先考慮與學術機構的檢驗，以加速轉化研究並驗證其臨床和消費者表現。

為確保絲素蛋白市場的供應韌性、監管合規性和差異化產品定位，經營團隊可採取實際的優先行動

致力於挖掘絲素蛋白潛力的產業領導者必須將短期行動與長期策略結合，才能將科學前景轉化為適銷產品。首先，他們應優先投資加強供應鏈韌性，具體措施包括原料來源多元化，以及與能夠檢驗已驗證製程規模的契約製造合作。這將有助於降低貿易政策波動帶來的風險，並確保受目標產品開發項目的持續性。其次，他們應在產品開發週期的早期階段就將監管策略納入考量。建立清晰的生物相容性和無菌性驗證路徑，將有助於降低後續風險，並加速臨床或商業核准。

採用全面透明的調查方法，結合面對面專家訪談、技術文獻綜述以及供應鏈和監管分析。

本研究整合了訪談、技術文獻綜述和供應鏈分析，對絲素蛋白的現狀進行了基於證據的評估。研究採用結構化訪談的方式，訪談了材料科學家、採購人員、臨床研究人員和生產專家，以了解技術限制和商業性趨勢。研究資訊來源與同行評審的、側重於材料表徵、生物相容性測試和生產流程最佳化的研究進行了交叉檢驗，以確保技術論點基於可重複的科學原理。

策略要務綜合分析表明，材料創新、監管協調和供應鏈韌性將決定絲素蛋白企業的長期成功。

絲素蛋白正處於一個策略轉折點，材料科學的突破、製造技術的創新以及採購重點的轉變在此交匯融合，催生出多種商業化路徑。絲素蛋白用途廣泛，涵蓋藥物傳遞、組織工程、創傷護理、化妝品配方和先進紡織品等領域，蘊藏著巨大的發展機會。然而，要充分發揮絲素蛋白的潛力，需要對可擴展的加工技術、監管策略和供應鏈韌性進行審慎的投資。那些在確保產品品質穩定可重複、並展現出卓越永續性下，優先發展絲素蛋白的企業，最有可能獲得持續的市場認可。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 絲素蛋白市場依產品類型分類

  • 纖維
  • 電影
  • 水凝膠
  • 粉末
  • 鷹架

9. 蠶絲纖維市場（按原始材料分類）

  • 蠶
    • 野生蠶
    • 完全馴化
  • 蜘蛛絲重組
    • 大腸桿菌表達
    • 哺乳動物細胞表達
    • 酵母表達

第10章 絲素蛋白市場及其應用

  • 生物醫學
    • 藥物輸送
    • 組織工程
    • 傷口敷料
  • 化妝品
    • 護髮
    • 護膚
  • 衛生保健
    • 植入
    • 縫合線
  • 纖維
    • 功能性布料
    • 智慧紡織品

第11章 以最終用戶分類的蠶絲素市場

  • 化妝品製造商
  • 醫院和診所
  • 製藥公司
  • 研究所
  • 紡織品製造商

第12章 各地區蠶絲纖維市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 絲素蛋白市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國蠶絲纖維市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章美國蠶絲纖維市場

第16章 中國蠶絲纖維市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced BioMatrix, LLC
  • AMSilk GmbH
  • Beijing Revotek Co., Ltd.
  • Croda International Plc
  • Evolved By Nature, Inc.
  • Fibroheal Pvt. Ltd.
  • Huzhou Xintiansi Bio-tech Co., Ltd.
  • LANXESS AG
  • Merck KGaA
  • Modern Meadow, Inc.
  • Nitta Gelatin, Inc.
  • Seidecosa SL
  • Silk Biomaterials（UK）Ltd.
  • Sofregen Medical Inc.
  • Spiber Inc.
Product Code: MRR-AE420CB13AAD

The Silk Fibroin Market was valued at USD 1.95 billion in 2025 and is projected to grow to USD 2.09 billion in 2026, with a CAGR of 9.23%, reaching USD 3.62 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.95 billion
Estimated Year [2026] USD 2.09 billion
Forecast Year [2032] USD 3.62 billion
CAGR (%) 9.23%

An authoritative orientation to silk fibroin that explains its multidisciplinary significance, material properties, and translational pathways for industry adoption

Silk fibroin has transcended its traditional association with textiles to become a widely studied functional biomaterial across multiple industries. Its unique amino acid composition and hierarchical structure impart high tensile strength, tunable biodegradability, and biocompatibility, which researchers and developers are leveraging to bridge gaps between laboratory science and commercial applications. Over the last decade, academic groups, startups, and industrial R&D teams have advanced processing methods that expand fibroin's form factors from fibers and films to hydrogels, powders, and scaffolds, enabling new design spaces for both regenerative medicine and high-performance textiles.

Today's landscape positions silk fibroin at the intersection of sustainability and performance. Manufacturers increasingly prioritize materials that reduce reliance on petrochemical polymers while delivering functional advantages such as moisture management, mechanical resilience, and controlled bioresorption. This shift has attracted multidisciplinary collaborations among dermatologists, materials scientists, textile engineers, and regulatory specialists who aim to translate fibroin-based innovations into clinically approved devices, consumer-facing personal care products, and integrated smart textile systems. As a result, the material's pathway from bench to market now involves simultaneous advances in scalable processing, regulatory strategy, and supply chain diversification.

Looking forward, successful adoption will hinge on the industry's ability to standardize characterization methods, demonstrate consistent raw material quality across sources, and validate long-term performance in real-world settings. These priorities frame the strategic choices manufacturers and investors must consider as they evaluate product portfolios and partnership opportunities in this rapidly evolving domain.

Critical technological, regulatory, and sustainability forces converging to accelerate silk fibroin commercialization across multiple sectors and applications

The past five years have seen several converging shifts that are reshaping how silk fibroin is researched, manufactured, and commercialized. Advances in recombinant protein expression and bioprocessing have diversified feedstocks beyond sericulture, enabling consistent supply chains and tailored molecular designs. Concurrently, additive manufacturing and precision electrospinning techniques have matured sufficiently to produce reproducible fibroin architectures at scales relevant for clinical and industrial use. These technological enablers reduce the historical barriers between proof-of-concept studies and regulated product development, accelerating iterative improvements and new application classes.

Market and policy drivers are reinforcing this technological momentum. Sustainability commitments from consumer brands and healthcare purchasers increasingly favor biodegradable and responsibly sourced materials, which strengthens the business case for fibroin-based alternatives to synthetic polymers. Regulatory agencies are also adapting guidance frameworks to accommodate biologically derived materials, prompting earlier engagement between developers and regulators and smoothing pathways for clinical evaluation. At the same time, shifting consumer expectations for clean-label cosmetics and advanced wound care solutions are expanding end-user demand across multiple sectors.

Together, these trends produce a landscape in which interdisciplinary collaboration, translational validation, and manufacturing scalability are the primary determinants of competitive advantage. Organizations that integrate upstream supply innovation with downstream regulatory and commercialization strategies will be best positioned to convert the current wave of research breakthroughs into durable market presence.

Assessment of how 2025 tariff policies have introduced strategic supply chain, sourcing, and partnership implications for silk fibroin stakeholders

The introduction of tariff measures by the United States in 2025 has introduced a new layer of complexity for global silk fibroin supply chains and pricing dynamics. Tariffs raise the cost base for imports of certain biopolymer feedstocks and intermediate products, which in turn pressures manufacturers to reassess sourcing strategies, nearshore production options, and vertical integration opportunities. Faced with these headwinds, some firms have accelerated investment in domestic production capabilities or sought alternative suppliers in tariff-exempt jurisdictions to preserve competitiveness.

In addition to immediate cost implications, tariff policy has prompted strategic reassessment around inventory management and contractual terms. Companies pursuing long-term product development now place greater emphasis on securing raw material quality and continuity through diversified supplier portfolios or licensed local manufacturing. This shift is especially salient for organizations developing regulated healthcare products, where supply chain disruptions can meaningfully delay clinical timelines and regulatory submissions. Consequently, procurement leaders and R&D teams are collaborating more closely to align material specifications with sourcing resilience.

Policy-driven cost variability also influences partnership decisions. Entities with strong manufacturing footholds within the United States, or those that can amortize tariff-related increases through scale, have gained negotiation leverage when forming alliances with startups or research consortia. Conversely, smaller innovators face higher entry barriers and may prioritize licensing agreements, joint development partnerships, or contract manufacturing relationships that mitigate exposure to cross-border tariff volatility. Ultimately, the 2025 tariff environment has underscored the strategic importance of supply chain design and the capacity to adapt commercial models in response to evolving trade policy.

Segmented analysis highlighting how application needs, product forms, end-user behaviors, and biological sources shape silk fibroin development strategies

Understanding market opportunities for silk fibroin requires careful segmentation by application, product form, end user, and biological source. In application terms, the material's versatility spans biomedical domains such as drug delivery, tissue engineering, and wound dressing; cosmetic formulations for hair care and skin care; healthcare devices including implants and sutures; and textile use cases that encompass both functional fabrics and smart textiles. Each application pathway imposes distinct performance criteria and regulatory expectations, shaping development priorities and required validation steps.

Product form further differentiates technical requirements and manufacturing workflows. Fibers offer tensile strength and are well suited to textile and suture applications, films provide barrier and surface functionality for wound interfaces and cosmetic patches, hydrogels support cell encapsulation and controlled release in regenerative medicine, powders enable formulation flexibility in both pharmaceutical and cosmetic contexts, and scaffolds present three-dimensional architectures necessary for tissue engineering constructs. These form factors influence processing choices, sterilization strategies, and compatibility with downstream manufacturing equipment.

End users determine commercialization routes and procurement behaviors. Cosmetic manufacturers prioritize formulation stability and consumer perceptions, hospitals and clinics emphasize clinical performance and supply reliability, pharmaceutical companies require stringent quality controls and scalability for drug-delivery applications, research institutes focus on material tunability for exploratory studies, and textile manufacturers seek integration pathways that preserve fabric performance while adding functionality. Source selection adds another layer of differentiation: materials derived from silkworm strains such as Antheraea pernyi and Bombyx mori offer established production pathways, while spider silk recombinant approaches-expressed in systems such as E. coli, mammalian cells, or yeast-enable sequence-level control and bespoke property tuning. Choosing among these segments requires balancing technical feasibility, regulatory clarity, and commercial considerations to align development trajectories with target customer needs.

Regional dynamics and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence silk fibroin commercialization and supply chains

Regional dynamics play a pivotal role in shaping research priorities, supply chain design, and commercialization pathways for silk fibroin. In the Americas, strong demand originates from translational biomedical research hubs and specialty textile manufacturers that prioritize integration with established clinical and consumer supply chains. Investors and corporates in this region often emphasize domestic manufacturing capability and regulatory alignment with national authorities, fostering partnerships that connect academic innovations with contract development and manufacturing organizations.

Europe, the Middle East & Africa represents a heterogeneous landscape where regulatory stringency, sustainability policy, and industrial capacity vary significantly across countries. European markets place high value on life-cycle analysis, biodegradability claims, and rigorous clinical evidence, which encourages conservative, evidence-driven adoption pathways. In parts of the Middle East and Africa, accelerated infrastructure development and strategic industrial programs can create pockets of demand for high-performance textiles and advanced medical products, though these opportunities typically require local partnership models and tailored market access strategies.

Asia-Pacific continues to be a leading center for both raw material production and advanced manufacturing capabilities, supported by well-established sericulture traditions and rapidly growing biotechnology sectors. Manufacturers in the region benefit from vertically integrated value chains, proximity to skilled process engineering talent, and cost-competitive production of recombinant proteins. These factors make the Asia-Pacific region a central node for scaling new fibroin technologies and for supplying global markets, particularly when companies seek to balance cost with material quality and innovation velocity.

Competitive landscape mapped by technological capability, manufacturing scale, and strategic partnerships that determine advantage in the silk fibroin value chain

Key companies operating in the silk fibroin ecosystem reveal a mix of specialized biotechnology firms, materials innovators, and established manufacturers adapting core capabilities to new product classes. Technology leaders invest in recombinant expression platforms, proprietary downstream purification methods, and scalable spinning or casting techniques that enable consistent material properties. These firms often prioritize partnerships with academic centers to accelerate translational research and validate clinical or consumer performance attributes.

At the same time, incumbent textile manufacturers and contract development organizations are incorporating fibroin processing into existing production lines, leveraging their expertise in quality management and large-scale fabrication. Their involvement signals a maturation of the value chain, where the path from specialized laboratory processes to commercially viable manufacturing becomes more predictable. Additionally, service providers offering regulatory consulting, sterilization validation, and biocompatibility testing play an increasingly essential role by shortening time-to-market and reducing technical risk for product developers.

Competitive differentiation is emerging along two vectors: technical control over molecular and microstructural attributes, and the ability to offer integrated commercialization services that encompass supply assurance, regulatory strategy, and market access. Companies that can demonstrate repeatable quality at scale, align product claims with rigorous evidence, and package offerings to meet end-user procurement models will enjoy the strongest traction across medical, cosmetic, and textile applications.

Practical and prioritized actions for executives to strengthen supply resilience, regulatory readiness, and differentiated product positioning in the silk fibroin market

Industry leaders seeking to capitalize on silk fibroin should align near-term actions with long-term positioning to convert scientific promise into marketable products. First, prioritize investments in supply chain resilience by diversifying raw material sources and engaging with contract manufacturers capable of scaling validated processes. This reduces exposure to trade policy fluctuations and ensures continuity for regulated product development programs. Second, integrate regulatory strategy early into product development cycles; establishing clear biocompatibility and sterility pathways will reduce downstream risk and accelerate clinical or commercial approvals.

Third, focus R&D resources on form factors and application niches where fibroin's intrinsic advantages-such as controlled biodegradation, mechanical strength, and favorable skin compatibility-deliver distinctive performance benefits. For example, targeting wound dressing platforms or specialty suture applications can create defensible product positions that leverage fibroin's material profile. Fourth, cultivate partnerships across academia, contract research organizations, and end-user institutions to co-develop validation studies that substantiate product claims while sharing development cost and expertise. Lastly, maintain transparent sustainability and traceability practices to meet evolving procurement standards and consumer expectations, documenting lifecycle impacts and supply chain provenance as part of standard commercial documentation.

By executing these strategic priorities, organizations can reduce technical and commercial risk while building credible narratives that accelerate adoption among clinicians, formulators, and textile integrators.

Comprehensive and transparent research methods combining primary expert interviews, technical literature synthesis, and supply chain and regulatory analysis

This research synthesizes primary interviews, technical literature reviews, and supply chain mapping to produce an evidence-based assessment of the silk fibroin landscape. Primary inputs included structured interviews with material scientists, procurement leaders, clinical researchers, and manufacturing experts to capture both technical constraints and commercial dynamics. These perspectives were cross-validated against peer-reviewed studies focused on material characterization, biocompatibility testing, and manufacturing process optimization to ensure technical assertions are grounded in reproducible science.

Supply chain analysis combined publicly available trade data, patent landscape evaluation, and process flow mapping to identify critical nodes and potential bottlenecks. Where possible, the study examined representative case studies of product development and scale-up to illustrate common pitfalls and successful mitigation strategies. Regulatory and policy analysis drew upon guidance documents and published approval pathways relevant to biologically derived materials, with emphasis on how these frameworks influence product development timelines and evidence requirements.

The methodology applied qualitative synthesis and triangulation to reconcile divergent viewpoints and to highlight areas of consensus. Limitations of the approach include variability in proprietary process data and the evolving nature of trade policy, which were addressed through scenario-based sensitivity in the analysis and by prioritizing sources with direct operational experience in production or clinical translation.

Synthesis of strategic imperatives demonstrating how material innovation, regulatory coordination, and supply resilience will determine long-term success for silk fibroin initiatives

Silk fibroin stands at a strategic inflection point where material science breakthroughs, manufacturing innovation, and shifting procurement priorities converge to create multiple commercialization pathways. Its versatility across drug delivery, tissue engineering, wound care, cosmetic formulation, and advanced textiles offers a breadth of opportunity, but realizing that potential depends on orchestrated investments in scalable processing, regulatory strategy, and supply chain resilience. Organizations that pursue these priorities while demonstrating reproducible quality and clear sustainability credentials are most likely to achieve sustained adoption.

The sector's near-term trajectory will be shaped by how stakeholders navigate trade policy dynamics, standardize characterization protocols, and build collaborative ecosystems that bridge laboratory innovation with clinical and consumer validation. Success will favor entities that combine molecular and microstructural control with practical competencies in manufacturing, evidence generation, and market access. By aligning technical development with real-world procurement and regulatory expectations, developers can accelerate translation and secure durable value across healthcare, cosmetics, and textile markets.

In sum, silk fibroin offers a compelling set of properties for next-generation materials, but its commercial maturity will hinge on disciplined execution across technical, regulatory, and operational domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Silk Fibroin Market, by Product Form

  • 8.1. Fiber
  • 8.2. Film
  • 8.3. Hydrogel
  • 8.4. Powder
  • 8.5. Scaffold

9. Silk Fibroin Market, by Source

  • 9.1. Silkworm
    • 9.1.1. Antheraea Pernyi
    • 9.1.2. Bombyx Mori
  • 9.2. Spider Silk Recombinant
    • 9.2.1. E. Coli Expressed
    • 9.2.2. Mammalian Cell Expressed
    • 9.2.3. Yeast Expressed

10. Silk Fibroin Market, by Application

  • 10.1. Biomedical
    • 10.1.1. Drug Delivery
    • 10.1.2. Tissue Engineering
    • 10.1.3. Wound Dressing
  • 10.2. Cosmetics
    • 10.2.1. Hair Care
    • 10.2.2. Skin Care
  • 10.3. Healthcare
    • 10.3.1. Implants
    • 10.3.2. Sutures
  • 10.4. Textile
    • 10.4.1. Functional Fabrics
    • 10.4.2. Smart Textiles

11. Silk Fibroin Market, by End User

  • 11.1. Cosmetic Manufacturers
  • 11.2. Hospitals & Clinics
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes
  • 11.5. Textile Manufacturers

12. Silk Fibroin Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Silk Fibroin Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Silk Fibroin Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Silk Fibroin Market

16. China Silk Fibroin Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced BioMatrix, LLC
  • 17.6. AMSilk GmbH
  • 17.7. Beijing Revotek Co., Ltd.
  • 17.8. Croda International Plc
  • 17.9. Evolved By Nature, Inc.
  • 17.10. Fibroheal Pvt. Ltd.
  • 17.11. Huzhou Xintiansi Bio-tech Co., Ltd.
  • 17.12. LANXESS AG
  • 17.13. Merck KGaA
  • 17.14. Modern Meadow, Inc.
  • 17.15. Nitta Gelatin, Inc.
  • 17.16. Seidecosa S.L.
  • 17.17. Silk Biomaterials (UK) Ltd.
  • 17.18. Sofregen Medical Inc.
  • 17.19. Spiber Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SILK FIBROIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SILK FIBROIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SILK FIBROIN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SILK FIBROIN MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SILK FIBROIN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SILK FIBROIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SILK FIBROIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SILK FIBROIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SILK FIBROIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SILK FIBROIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SILK FIBROIN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SILK FIBROIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SILK FIBROIN MARKET SIZE, BY FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SILK FIBROIN MARKET SIZE, BY FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SILK FIBROIN MARKET SIZE, BY FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SILK FIBROIN MARKET SIZE, BY FILM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SILK FIBROIN MARKET SIZE, BY FILM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SILK FIBROIN MARKET SIZE, BY FILM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SILK FIBROIN MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SILK FIBROIN MARKET SIZE, BY HYDROGEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SILK FIBROIN MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SILK FIBROIN MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SILK FIBROIN MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SILK FIBROIN MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SILK FIBROIN MARKET SIZE, BY SCAFFOLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SILK FIBROIN MARKET SIZE, BY SCAFFOLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SILK FIBROIN MARKET SIZE, BY SCAFFOLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SILK FIBROIN MARKET SIZE, BY SILKWORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SILK FIBROIN MARKET SIZE, BY SILKWORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SILK FIBROIN MARKET SIZE, BY SILKWORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SILK FIBROIN MARKET SIZE, BY ANTHERAEA PERNYI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SILK FIBROIN MARKET SIZE, BY ANTHERAEA PERNYI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SILK FIBROIN MARKET SIZE, BY ANTHERAEA PERNYI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SILK FIBROIN MARKET SIZE, BY BOMBYX MORI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SILK FIBROIN MARKET SIZE, BY BOMBYX MORI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SILK FIBROIN MARKET SIZE, BY BOMBYX MORI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SILK FIBROIN MARKET SIZE, BY E. COLI EXPRESSED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SILK FIBROIN MARKET SIZE, BY E. COLI EXPRESSED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SILK FIBROIN MARKET SIZE, BY E. COLI EXPRESSED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SILK FIBROIN MARKET SIZE, BY MAMMALIAN CELL EXPRESSED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SILK FIBROIN MARKET SIZE, BY MAMMALIAN CELL EXPRESSED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SILK FIBROIN MARKET SIZE, BY MAMMALIAN CELL EXPRESSED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SILK FIBROIN MARKET SIZE, BY YEAST EXPRESSED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SILK FIBROIN MARKET SIZE, BY YEAST EXPRESSED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SILK FIBROIN MARKET SIZE, BY YEAST EXPRESSED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SILK FIBROIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SILK FIBROIN MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SILK FIBROIN MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SILK FIBROIN MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SILK FIBROIN MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SILK FIBROIN MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SILK FIBROIN MARKET SIZE, BY WOUND DRESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SILK FIBROIN MARKET SIZE, BY WOUND DRESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SILK FIBROIN MARKET SIZE, BY WOUND DRESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SILK FIBROIN MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SILK FIBROIN MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SILK FIBROIN MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SILK FIBROIN MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SILK FIBROIN MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SILK FIBROIN MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SILK FIBROIN MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SILK FIBROIN MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SILK FIBROIN MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SILK FIBROIN MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SILK FIBROIN MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SILK FIBROIN MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SILK FIBROIN MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SILK FIBROIN MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SILK FIBROIN MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SILK FIBROIN MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SILK FIBROIN MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SILK FIBROIN MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SILK FIBROIN MARKET SIZE, BY TEXTILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SILK FIBROIN MARKET SIZE, BY TEXTILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SILK FIBROIN MARKET SIZE, BY TEXTILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SILK FIBROIN MARKET SIZE, BY FUNCTIONAL FABRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SILK FIBROIN MARKET SIZE, BY FUNCTIONAL FABRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SILK FIBROIN MARKET SIZE, BY FUNCTIONAL FABRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SILK FIBROIN MARKET SIZE, BY SMART TEXTILES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SILK FIBROIN MARKET SIZE, BY SMART TEXTILES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SILK FIBROIN MARKET SIZE, BY SMART TEXTILES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SILK FIBROIN MARKET SIZE, BY COSMETIC MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SILK FIBROIN MARKET SIZE, BY COSMETIC MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SILK FIBROIN MARKET SIZE, BY COSMETIC MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SILK FIBROIN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SILK FIBROIN MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SILK FIBROIN MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SILK FIBROIN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SILK FIBROIN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SILK FIBROIN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SILK FIBROIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SILK FIBROIN MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SILK FIBROIN MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SILK FIBROIN MARKET SIZE, BY TEXTILE MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SILK FIBROIN MARKET SIZE, BY TEXTILE MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SILK FIBROIN MARKET SIZE, BY TEXTILE MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SILK FIBROIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SILK FIBROIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL SILK FIBROIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. GCC SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 205. GCC SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 207. GCC SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 208. GCC SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. GCC SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 210. GCC SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. G7 SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 238. G7 SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 240. G7 SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 241. G7 SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 243. G7 SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. NATO SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 249. NATO SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 251. NATO SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 252. NATO SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 254. NATO SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 256. NATO SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL SILK FIBROIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES SILK FIBROIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA SILK FIBROIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA SILK FIBROIN MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA SILK FIBROIN MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA SILK FIBROIN MARKET SIZE, BY SILKWORM, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA SILK FIBROIN MARKET SIZE, BY SPIDER SILK RECOMBINANT, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA SILK FIBROIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA SILK FIBROIN MARKET SIZE, BY BIOMEDICAL, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA SILK FIBROIN MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA SILK FIBROIN MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA SILK FIBROIN MARKET SIZE, BY TEXTILE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA SILK FIBROIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)